Skip to main content

Immunitas Therapeutics, INC

Waltham, MA
United States

TAP Partner

Immunitas is a single cell genomics-based therapeutics company focused on immunology that is advancing multiple programs to the clinic. Immunitas’ programs are derived from their platform, a cross-functional, highly integrated, single cell genomics approach that enables rapid target identification and validation in parallel with antibody discovery and engineering.

Program Name(s)
Therapy Acceleration Program